Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab vedotin)

• Catalog Number: orb1805473
• Category: Antibodies
• Description: Anti-TNFRSF8 / CD30 Reference Antibody and Monomethyl auristatin E (MMAE) that inhibits CD30-positive cells and is used for the study of relapsed and refractory Hogkin's lymphoma.
• Clonality: Monoclonal
• Tested applications: ELISA, FA, FACS, Kinetics
• Reactivity: Human
• Isotype: IgG
• Purity: > 95%
• Conjugation: Unconjugated
• MW: 145.38 kDa
• Target: TNFRSF8 / CD30
• Endotoxins: < 1 EU/mg
• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
• Buffer/Preservatives: 100 mM Pro-Ac 20 mM Arg pH 5.0
• Note: For research use only
• Expiration Date: 12 months from date of receipt.

Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab vedotin) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.

The purity of Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab vedotin)is more than 98.99% ;determined by SEC-HPLC.

Immobilized human CD30 His at 2 μg/mL can bind Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab vedotin);EC50=0.006007μg/mL.